Alere Inc (ALR.N)
34.29USD
12:54pm EDT
$0.13 (+0.38%)
$34.16
$34.20
$34.60
$34.04
121,631
150,825
$35.35
$17.13
About
Overall
| Beta: | 1.59 |
| Market Cap (Mil.): | $2,778.50 |
| Shares Outstanding (Mil.): | 81.34 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ALR.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 67.23 | 37.87 |
| EPS (TTM): | -1.68 | -- | -- |
| ROI: | -2.00 | 5.02 | 18.70 |
| ROE: | -7.52 | 9.82 | 19.53 |
Activist investor sees Alere shares soaring if asset sales plan adopted
NEW YORK - An activist shareholder, which has been battling Alere Inc's management, said investors could more than double the value of their stock if they backed a plan for the health diagnostics and services provider to offload assets.
Activist investor sees Alere shares soaring if asset sales plan adopted
NEW YORK, July 8 - An activist shareholder, which has been battling Alere Inc's management, said investors could more than double the value of their stock if they backed a plan for the health diagnostics and services provider to offload assets.
Exclusive: Activist investor sends Alere letter calling for unit sales
NEW YORK - An activist investor who has been campaigning for change at Alere Inc sent the company a letter on Monday calling for the health diagnostics and services company to sell three of its businesses, which it believes can yield more than $3 billion in proceeds.
Activist investor wants Alere to explore $2.5 billion unit sale: sources
NEW YORK - An activist investor in Alere Inc wants the health diagnostics and services company to explore a sale of its drug testing business, which it believes could fetch as much as $2.5 billion and help Alere pay down debt, two people familiar with the matter said on Tuesday.
Activist investor wants Alere to explore $2.5 bln unit sale -sources
NEW YORK, May 21 - An activist investor in Alere Inc wants the health diagnostics and services company to explore a sale of its drug testing business, which it believes could fetch as much as $2.5 billion and help Alere pay down debt, two people familiar with the matter said on Tuesday.
Competitors
| Price | Change | |
|---|---|---|
| Tosoh Corporation (4042.T) | ¥366 | +17.00 |
| Wal-Mart Stores, Inc. (WMT.N) | $78.61 | +0.39 |
| CVS Caremark Corporation (CVS.N) | $62.05 | -0.12 |
| McKesson Corporation (MCK.N) | $122.99 | -0.52 |
| Siemens AG (SIEGn.DE) | €83.75 | -0.70 |
| Walgreen Company (WAG.N) | $50.98 | -0.15 |
| Johnson & Johnson (JNJ.N) | $93.88 | +0.11 |
| Roche Holding Ltd. (ROG.VX) | CHF228.70 | +0.70 |
| Abbott Laboratories (ABT.N) | $36.83 | -0.01 |
| Becton, Dickinson and Co. (BDX.N) | $101.65 | -1.46 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: MacroRisk Analytics/EconomicInvestor
|
$15.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

